93 related articles for article (PubMed ID: 7578599)
21. Continued malignant cell proliferation in head and neck tumors during cytotoxic therapy.
Preisler HD; Kotelnikov VM; LaFollette S; Taylor S; Mundle S; Wood N; Coon JS; Hutchinson J; Panje W; Caldarelli DD; Griem K
Clin Cancer Res; 1996 Sep; 2(9):1453-60. PubMed ID: 9816320
[TBL] [Abstract][Full Text] [Related]
22. Accuracy of immunohistochemistry and flow cytometry in estimating the proportion of leukemic cells in S phase in chronic myeloid leukemia patients.
Hegde U; Kotelnikov VM; Handa H; Burke P; Preisler HD
Leuk Lymphoma; 1996 Aug; 22(5-6):431-7. PubMed ID: 8882956
[TBL] [Abstract][Full Text] [Related]
23. The EGF receptor system in head and neck carcinomas and normal tissues. Immunohistochemical and quantitative studies.
Christensen ME
Dan Med Bull; 1998 Apr; 45(2):121-34. PubMed ID: 9587699
[TBL] [Abstract][Full Text] [Related]
24. Sequential increases in proliferating cell nuclear antigen expression in head and neck tumorigenesis: a potential biomarker.
Shin DM; Voravud N; Ro JY; Lee JS; Hong WK; Hittelman WN
J Natl Cancer Inst; 1993 Jun; 85(12):971-8. PubMed ID: 8098774
[TBL] [Abstract][Full Text] [Related]
25. Selective radiosensitization of drug-resistant MutS homologue-2 (MSH2) mismatch repair-deficient cells by halogenated thymidine (dThd) analogues: Msh2 mediates dThd analogue DNA levels and the differential cytotoxicity and cell cycle effects of the dThd analogues and 6-thioguanine.
Berry SE; Davis TW; Schupp JE; Hwang HS; de Wind N; Kinsella TJ
Cancer Res; 2000 Oct; 60(20):5773-80. PubMed ID: 11059773
[TBL] [Abstract][Full Text] [Related]
26. Cell production rates in human tissues and tumours and their significance. Part II: clinical data.
Rew DA; Wilson GD
Eur J Surg Oncol; 2000 Jun; 26(4):405-17. PubMed ID: 10873364
[TBL] [Abstract][Full Text] [Related]
27. Multiparameter analysis of vasculature, perfusion and proliferation in human tumour xenografts.
Bussink J; Kaanders JH; Rijken PF; Martindale CA; van der Kogel AJ
Br J Cancer; 1998; 77(1):57-64. PubMed ID: 9459146
[TBL] [Abstract][Full Text] [Related]
28. Chemoradiotherapy as an alternative to radiotherapy alone in fast proliferating head and neck squamous cell carcinomas.
Corvó R; Giaretti W; Sanguineti G; Geido E; Bacigalupo A; Orecchia R; Benasso M; Numico GM; Merlano M; Margarino G; Vitale V
Clin Cancer Res; 1997 Nov; 3(11):1993-7. PubMed ID: 9815589
[TBL] [Abstract][Full Text] [Related]
29. Studies with bromodeoxyuridine in head and neck cancer and accelerated radiotherapy.
Wilson GD; Dische S; Saunders MI
Radiother Oncol; 1995 Sep; 36(3):189-97. PubMed ID: 8532905
[TBL] [Abstract][Full Text] [Related]
30. Factors influencing the estimates of proliferative labelling indices in rectal cancer.
Bergström C; Palmqvist R; Denekamp J; Oberg A; Tavelin B; Stenling R
Radiother Oncol; 1998 Feb; 46(2):169-77. PubMed ID: 9510044
[TBL] [Abstract][Full Text] [Related]
31. Use of thymidine analogues to indicate vascular perfusion in tumours.
Begg AC; Hofland I; Van Der Pavert I; Van Der Schueren B; Haustermans K
Br J Cancer; 2000 Oct; 83(7):899-905. PubMed ID: 10970692
[TBL] [Abstract][Full Text] [Related]
32. In vivo cell kinetics in head and neck squamous cell carcinomas predicts local control and helps guide radiotherapy regimen.
Corvò R; Giaretti W; Sanguineti G; Geido E; Orecchia R; Guenzi M; Margarino G; Bacigalupo A; Garaventa G; Barbieri M
J Clin Oncol; 1995 Aug; 13(8):1843-50. PubMed ID: 7636527
[TBL] [Abstract][Full Text] [Related]
33. Comparison of BrdUrd and [3H]TdR incorporation to estimate cell proliferation, cell loss, and potential doubling time in tumor xenografts.
Zätterström UK; Johansson M; Källén A; Baldetorp B; Oredsson S; Wennerberg J; Killander D
Cytometry; 1992; 13(8):872-9. PubMed ID: 1459003
[TBL] [Abstract][Full Text] [Related]
34. [In vivo evaluation of potential doubling time (Tpot) of tumors by flow cytometry: practical difficulties and possible solutions].
Gorisse MC; Desoize B; Carpentier Y; Nguyen TD
Bull Cancer; 1996 Oct; 83(10):825-34. PubMed ID: 8952632
[TBL] [Abstract][Full Text] [Related]
35. Ataxia telangiectasia cells exhibit the same radiosensitization response by incorporation of BrdUrd or IdUrd as do normal human cells.
Raaphorst GP; Azzam EI; Vadasz JA
Radiat Res; 1985 Sep; 103(3):455-60. PubMed ID: 4034938
[TBL] [Abstract][Full Text] [Related]
36. Region-specific DNA synthesis in brains of F344 rats following a six-day bromodeoxyuridine infusion.
Bolon B; Dunn C; Goldsworthy TL
Cell Prolif; 1996 Sep; 29(9):505-11. PubMed ID: 8980657
[TBL] [Abstract][Full Text] [Related]
37. [The in vivo use of bromodeoxyuridine for the study of cell kinetics in squamous tumors of the neck and head. Implications for the radiotherapist].
Corvò R; Giaretti W; Margarino G; Danova M; Vitale V
Radiol Med; 1991; 82(1-2):147-52. PubMed ID: 1896568
[TBL] [Abstract][Full Text] [Related]
38. Beta 2-microglobulin in squamous cell carcinomas of the head and neck and in tumours heterotransplanted into nude athymic mice.
Wennerberg J; Alm P; Lögdberg L; Tropé C
Acta Otolaryngol; 1984; 98(3-4):335-42. PubMed ID: 6388230
[TBL] [Abstract][Full Text] [Related]
39. Quantitative immunohistochemical analysis of transforming growth factor-alpha and epidermal growth factor receptor in patients with squamous cell carcinoma of the head and neck.
Rubin Grandis J; Melhem MF; Barnes EL; Tweardy DJ
Cancer; 1996 Sep; 78(6):1284-92. PubMed ID: 8826952
[TBL] [Abstract][Full Text] [Related]
40. Labelling indices in human tumours: to apply corrections or not--that is the question.
Bergström C; Begg A; Palmqvist R; Waites A; Denekamp J
Br J Cancer; 1999 Jul; 80(10):1635-43. PubMed ID: 10408411
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
